Hepatitis C is the leading blood borne infection, and the number one cause of liver disease in the United States. The Center for Disease Control estimates that 2.7 million people in the US are ...
For decades, many Americans with hepatitis C have struggled to get tested or died waiting for a cure that remained inaccessibly expensive within the nation’s fractured health care system. President ...
Epclusa (sofosbuvir/velpatasvir) is a brand-name prescription medication. It’s approved by the Food and Drug Administration (FDA) to treat hepatitis C, which is an ...
A Stanford study shows that jail-based hepatitis C programs could cut new infections by nearly half among people who inject ...
Hepatitis is a condition that occurs when your liver becomes inflamed. There are several things that can cause hepatitis, including viral infections, autoimmune conditions, and heavy alcohol use. Many ...
For a decade now, the world has had highly effective medications for hepatitis C infections. In the United States, they’ve mostly been sitting on the shelf, according to a new study. These drugs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results